StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)

StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Bank of America lowered shares of FibroGen from a neutral rating to an underperform rating and dropped their price objective for the stock from $4.00 to […]

Leave a Reply

Your email address will not be published.

Previous post Intuit (NASDAQ:INTU) PT Raised to $610.00 at Oppenheimer
Next post Raymond James Increases Micron Technology (NASDAQ:MU) Price Target to $82.00